Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
about
PNPLA3 mediates hepatocyte triacylglycerol remodelingGenetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to managementRole of NLRP3 Inflammasome in the Progression of NAFLD to NASHThe Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundAlcoholic liver disease and hepatitis C virus infectionTM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver DiseaseNutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin ResistanceGenetic background in nonalcoholic fatty liver disease: A comprehensive reviewGenetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisAssociation of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-AnalysisDoes Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentReview article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewHow Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesRecent advances in understanding/management of non-alcoholic steatohepatitis.Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicineSexually dimorphic genome-wide binding of retinoid X receptor alpha (RXRα) determines male-female differences in the expression of hepatic lipid processing genes in miceGlucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver diseaseGenetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patientsHepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review.Genetic predisposition in nonalcoholic fatty liver disease.Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children.Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease.PNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patients.Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population.Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease.Gender and racial differences in nonalcoholic fatty liver disease.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).Non-alcoholic fatty liver disease: An expanded reviewGenetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma
P2860
Q24336530-64314362-330E-4E64-84F7-4CF448F2D6CDQ26741557-3A4248A0-22FE-4A29-8C52-885E1A9E4555Q26742102-AB9044C1-9D6F-46AD-B33F-3849287B4273Q26744380-5C185234-7441-4C3A-A1D5-B27DA58690A1Q26773274-59B30272-4075-447E-AB61-5EEBA0EDFC01Q26774883-31784A4E-9255-4117-AF17-FF82C4B2D9FFQ26778135-05E6D844-CE8C-45BF-B25E-B666430EBDFBQ26780248-091F4A11-1B18-42F3-AFD4-AC6C9E727F50Q26798151-83D297A4-7FC1-4BCC-B235-E3331D3DE729Q26798155-753F7F3D-359E-42F4-B749-F3584D7E67A0Q26798161-D9EBB21F-7CD7-4E60-B275-80976BD53BF3Q26828855-2021D813-9035-42EF-B547-5ECC5C8DC25FQ26852019-F93653EF-DBE7-4D9D-8C26-0948183831A7Q26998093-5329733B-7907-452B-9F48-4BAE31CEDDB2Q28070408-B91B6CBB-8D5B-4BD4-878E-CE1804952C9EQ28074455-931A3814-79FB-4F4D-8305-C22E8B596DF4Q28081216-E46F1023-8801-4D86-B835-0A7A67FCCC46Q28085689-796C1164-9E49-4BB3-B322-E11A54E3B2A5Q28086887-535D7B56-50F6-4A25-A072-E552774FAB59Q28535445-8726ACA5-6A40-4A97-B58B-CC4872A4630EQ28539434-5D58F5B9-8CF2-4981-9117-446650CDCA2DQ29417094-D4E11004-380C-4061-900F-F6BE400EB79AQ29994538-D8ED1B9F-BE13-4431-9F48-FBB721C685C7Q30234574-52477170-1F79-4655-BE2C-E812E1A52BFAQ30234676-56227FD5-1E32-42DE-A5D7-C351914F51FEQ30235398-CE21D962-C268-4BBD-943A-82798F142A39Q30241387-4DBC920F-C26A-4DD8-BD80-9E40A09CA592Q30241654-3AB59E3A-30B6-4A16-B3A0-394D31B6BC95Q30396692-FABB5246-39F1-402E-9413-2F4806E69AA4Q30418176-6513C67E-B265-4E33-8F9D-15CADCB944ECQ30589720-648206D5-9011-4D6E-8653-7AF8825BCD81Q30675355-450AFAEA-6AB1-4221-AE76-B68557F27295Q30747665-BAD9FFE5-B7F0-4742-B198-220BF5840242Q30830629-D0A7D08F-C632-4B55-BFA8-23E04CB1091BQ33618518-9C22201A-C55B-4212-9D7A-B9A845C9CE23Q33660001-455DD6A2-93FC-4FA7-913A-002081218A7DQ33755566-99F80DAB-E95F-42C0-8698-DF35CD46D25EQ33778556-479992C8-DE50-4A10-AC16-FB0D743B709CQ33789868-41FD74D0-F28B-443E-83E6-0442AA980040Q33798871-9E78A567-5A6F-4B7A-B8A1-6DDDBBFBFFAD
P2860
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Meta-analysis of the influence ...... alcoholic fatty liver disease.
@en
Meta-analysis of the influence ...... ipase domain containing 3 gene
@nl
type
label
Meta-analysis of the influence ...... alcoholic fatty liver disease.
@en
Meta-analysis of the influence ...... ipase domain containing 3 gene
@nl
prefLabel
Meta-analysis of the influence ...... alcoholic fatty liver disease.
@en
Meta-analysis of the influence ...... ipase domain containing 3 gene
@nl
P2860
P356
P1433
P1476
Meta-analysis of the influence ...... alcoholic fatty liver disease.
@en
P2093
Carlos J Pirola
Silvia Sookoian
P2860
P304
P356
10.1002/HEP.24283
P407
P577
2011-05-14T00:00:00Z